VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 424 filers reported holding VANECK VECTORS ETF TR in Q4 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,617,500 | -59.9% | 50,000 | +4657.4% | 2.06% | -58.8% |
| Q1 2022 | $4,031,000 | +0.7% | 1,051 | -15.9% | 5.02% | +69.2% |
| Q4 2021 | $4,004,000 | -52.9% | 1,250 | -99.5% | 2.97% | -13.7% |
| Q2 2021 | $8,495,000 | +354.5% | 250,000 | +334.8% | 3.44% | +366.5% |
| Q1 2021 | $1,869,000 | -93.2% | 57,500 | +8114.3% | 0.74% | -95.7% |
| Q3 2020 | $27,412,000 | +453.2% | 700 | -99.5% | 17.18% | +203.2% |
| Q2 2020 | $4,955,000 | +109.8% | 135,100 | +31.8% | 5.67% | +25.0% |
| Q1 2020 | $2,362,000 | -22.0% | 102,500 | -1.0% | 4.53% | +144.6% |
| Q4 2019 | $3,030,000 | +310.6% | 103,500 | +195.7% | 1.85% | +173.3% |
| Q4 2018 | $738,000 | – | 35,000 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |